Kala Pharmaceuticals, Inc.
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
29 Jul 2021
Issue date:
18 Nov 2021